Für diesen Artikel ist leider kein Bild verfügbar.

Liquid Biopsy for Cancer

Current Status and Future Challenges
Buch | Hardcover
150 Seiten
2025
Springer Verlag, Singapore
978-981-99-4417-0 (ISBN)
117,69 inkl. MwSt
  • Titel nicht im Sortiment
  • Artikel merken
lt;p>Individual tumour molecular profiling and tacking dynamic evolution by treatment related selective pressure are crucial for clinical oncology. However, current tissue biopsy cannot represent spatial and temporal tumour heterogeneity due to sampling bias. 

Liquid biopsy is an alternative way of tissue biopsy since it can represent comprehensive molecular signature from multiple distinct lesions and real time tracking is feasible by repeated longitudinal assay during course of treatment.

This book describes current knowledge regarding pre-analytical issues including standardization of blood preparation, analytical variability, clinical application and regulatory agency approval issue, etc. Regarding targets in circulation, it focuses on circulating tumour cells (CTCs), circulating nucleic acid (ctDNA, cell free RNAs), extracellular vesicles, tumour educated platelets, and others (proteins, metabolites).

The book will be a rich source of information and instruction for oncologists and offers stimulating ideas on prospects for further progress in this field.

Seung Il Kim, MD, PhD. Professor., Department of Medical Oncology, Yonsei University College of Medicine Jee Ye Kim, MD, PhD. Professor., Department of Medical Oncology, Yonsei University College of Medicine

1. Introduction.- 2. Technical issue for implementation of liquid biopsy.- 3. Targets in circulation.- A. circulating tumour cells (CTCs).- B. circulating nucleic acid (ctDNA, cell free RNAs).- C. extracellular vesicles.- D. tumour educated platelets.- E. others (proteins, metabolites).- 4. Liquid biopsy as cancer screening: early cancer detection in general population.- 5. Liquid biopsy for patients with cancer.- A. treatment response monitoring.- B. MRD monitoring: early detection of recurrence.- C. Resistance mechanism tracking.- 6. Future perspectives.

Erscheint lt. Verlag 12.4.2025
Zusatzinfo 5 Illustrations, color; 10 Illustrations, black and white; Approx. 150 p. 15 illus., 5 illus. in color.
Verlagsort Singapore
Sprache englisch
Maße 178 x 254 mm
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Studium 2. Studienabschnitt (Klinik) Pathologie
Schlagworte Cancer Screening • circulating tumour cells • ctDNA • Liquid Biopsy • treatment monitoring
ISBN-10 981-99-4417-1 / 9819944171
ISBN-13 978-981-99-4417-0 / 9789819944170
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Thomas Kirchner; Hans Konrad Müller-Hermelink …

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
42,00
Klinisch-pathologische Übersichtskarten

von Thomas Cerny; Kirill Karlin

Buch | Hardcover (2023)
Springer (Verlag)
34,99